These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

889 related items for PubMed ID: 16925797

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 3. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
    Baron F, Schaaf-Lafontaine N, Humblet-Baron S, Meuris N, Castermans E, Baudoux E, Frère P, Bours V, Fillet G, Beguin Y.
    Transplantation; 2003 Dec 27; 76(12):1705-13. PubMed ID: 14688520
    [Abstract] [Full Text] [Related]

  • 4. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D.
    Klin Padiatr; 2004 Dec 27; 216(6):356-63. PubMed ID: 15565551
    [Abstract] [Full Text] [Related]

  • 5. Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts unselected PBPC grafts or BM grafts.
    Behringer D, Bertz H, Schmoor C, Berger C, Dwenger A, Finke J.
    Bone Marrow Transplant; 1999 Aug 27; 24(3):295-302. PubMed ID: 10455369
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation.
    Kim DH, Won DI, Lee NY, Sohn SK, Suh JS, Lee KB.
    Biol Blood Marrow Transplant; 2006 Jul 27; 12(7):719-28. PubMed ID: 16785061
    [Abstract] [Full Text] [Related]

  • 8. Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.
    Koehl U, Bochennek K, Zimmermann SY, Lehrnbecher T, Sörensen J, Esser R, Andreas C, Kramm C, Grüttner HP, Falkenberg E, Orth A, Bader P, Schwabe D, Klingebiel T.
    Bone Marrow Transplant; 2007 Mar 27; 39(5):269-78. PubMed ID: 17311085
    [Abstract] [Full Text] [Related]

  • 9. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
    Barge RM, Brouwer RE, Beersma MF, Starrenburg CW, Zwinderman AH, Hale G, Waldmann H, den Ottolander GJ, Falkenburg JH, Willemze R, Fibbe WE.
    Bone Marrow Transplant; 2001 May 27; 27(10):1053-8. PubMed ID: 11438820
    [Abstract] [Full Text] [Related]

  • 10. Dendritic cell recovery after autologous stem cell transplantation.
    Damiani D, Stocchi R, Masolini P, Michelutti A, Sperotto A, Geromin A, Skert C, Cerno M, Michieli M, Baccarani M, Fanin R.
    Bone Marrow Transplant; 2002 Sep 27; 30(5):261-6. PubMed ID: 12209346
    [Abstract] [Full Text] [Related]

  • 11. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA, Sims-Poston L, Eldridge P, Hale GA.
    Biol Blood Marrow Transplant; 2007 May 27; 13(5):608-14. PubMed ID: 17448921
    [Abstract] [Full Text] [Related]

  • 12. [A comparative study of unrelated donor bone marrow transplantation and peripheral blood stem cell transplantation for their therapeutic effects on leukemia].
    Fan ZP, Yang K, Liu QF, Sun J, Xu D, Zhang Y, Wei YQ, Ye CX, Jiang QL, Meng FY.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct 27; 26(10):1494-7, 1512. PubMed ID: 17062361
    [Abstract] [Full Text] [Related]

  • 13. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H, Watanabe T, Suzuya H, Wakata Y, Kaneko M, Onishi T, Okamoto Y, Abe T, Kawano Y, Kagami S, Takaue Y.
    Bone Marrow Transplant; 2006 Apr 27; 37(7):661-8. PubMed ID: 16489358
    [Abstract] [Full Text] [Related]

  • 14. A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.
    Eyrich M, Leiler C, Lang P, Schilbach K, Schumm M, Bader P, Greil J, Klingebiel T, Handgretinger R, Niethammer D, Schlegel PG.
    Bone Marrow Transplant; 2003 Aug 27; 32(4):379-90. PubMed ID: 12900774
    [Abstract] [Full Text] [Related]

  • 15. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE, van der Holt B, Haze S, Braakman E, Gratama JW, Löwenberg B, Cornelissen JJ.
    Exp Hematol; 2005 Aug 27; 33(8):912-9. PubMed ID: 16038784
    [Abstract] [Full Text] [Related]

  • 16. A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors.
    Petersen SL, Ryder LP, Björk P, Madsen HO, Heilmann C, Jacobsen N, Sengeløv H, Vindeløv LL.
    Bone Marrow Transplant; 2003 Jul 27; 32(1):65-72. PubMed ID: 12815480
    [Abstract] [Full Text] [Related]

  • 17. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease.
    Abrahamsen IW, Sømme S, Heldal D, Egeland T, Kvale D, Tjønnfjord GE.
    Haematologica; 2005 Jan 27; 90(1):86-93. PubMed ID: 15642674
    [Abstract] [Full Text] [Related]

  • 18. Frequent viral infections and delayed CD4+ cell recovery following CD34+ cell-selected autologous peripheral blood stem cell transplantation.
    Takeshima M, Takamatsu H, Iida M, Mochizuki Y, Okumura H, Yoshida T.
    Int J Hematol; 1999 Oct 27; 70(3):193-9. PubMed ID: 10561914
    [Abstract] [Full Text] [Related]

  • 19. Differences between graft product and donor side effects following bone marrow or stem cell donation.
    Favre G, Beksaç M, Bacigalupo A, Ruutu T, Nagler A, Gluckman E, Russell N, Apperley J, Szer J, Bradstock K, Buzyn A, Matcham J, Gratwohl A, Schmitz N, European Group for Blood and Marrow Transplantation (EBMT).
    Bone Marrow Transplant; 2003 Nov 27; 32(9):873-80. PubMed ID: 14561987
    [Abstract] [Full Text] [Related]

  • 20. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
    Chang YJ, Zhao XY, Huang XJ.
    Biol Blood Marrow Transplant; 2008 Mar 27; 14(3):323-34. PubMed ID: 18275899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.